Preclinical
Researchers discovered a pathway that helps regulate inflammation and also prevents the buildup of toxic proteins related to Alzheimer’s.
Using human induced pluripotent stem cells (iPSCs), researchers with Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California, were able to grow natural-looking hair that grows through the skin.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Researchers at Oregon State University recently improved on a technique using magnetic nanoclusters. Their research was published in May in the journal ACS Nano.
Ongoing pivotal Phase II clinical trial of ADCT-402 in patients with relapsed or refractory diffuse large B-cell lymphoma anticipated to complete enrollment in third quarter of 2019
Although progress has been made in treating the disease, it’s still often fatal, and is made up of multiple diseases.
Orion Biotechnology Canada Ltd., announced new preclinical data evaluating the efficacy of OB-002 in colorectal cancer.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Balixafortide is the most advanced and only CXCR4 antagonist in development in a pivotal Oncology global registration trial.
Retrophin, Inc. announced that it has entered into a three-way Cooperative Research and Development Agreement with the National Institutes of Health’s National Center for Advancing Translational Sciences and patient advocacy foundation Alagille Syndrome Alliance to collaborate on research efforts aimed at the identification and development of potentially novel therapeutics for Alagille syndrome.
PRESS RELEASES